Results 151 to 160 of about 24,692 (192)

The benefit of scratch patch testing to demonstrate ocular contact allergy to brimonidine tartrate

Contact Dermatitis, 2022
Ocular allergies to brimonidine are frequent in patients treated for glaucoma. There is variability in reporting due to the lack of diagnostic criteria and the absence of cutaneous testing.
J. Ringuet, C. Lajoie, S. Bourgault, D. Simonyan, M. Houle   +4 more
semanticscholar   +1 more source

Inflammatory Cells and Lipid Deposits Detected by in Vivo Confocal Microscopy in Brimonidine Tartrate Ophthalmic Solution-Related Corneal Disorders: A Case Series

Ocular immunology and inflammation, 2022
We reviewed the medical charts of five patients diagnosed with brimonidine tartrate (BT)-related corneal disorders. A fan-shaped corneal opacity was present in four patients and limbal corneal infiltrations were present in one patient.
T. Chikama, Koichiro Shinji, Chika Yokota, Ken Hayashi, Yoshiaki Kiuchi   +4 more
semanticscholar   +1 more source

Vitreous concentration of topically applied brimonidine tartrate 0.2%

Ophthalmology, 2001
To determine the vitreous concentration of brimonidine after topical administration of Alphagan.Prospective observational case series.Eighteen patients scheduled for elective pars plana vitrectomy.Brimonidine tartrate, 0.2%, was topically administered twice or three times daily for 4 to 14 days preoperatively in 13 patients.
Robert David, Farrell Tyson, Jonathan D. Nussdorf, Dan Fellows, Alexander R. Kent, David Small   +5 more
openaire   +3 more sources

Formulation design and optimization of cationic-charged liposomes of brimonidine tartrate for effective ocular drug delivery by design of experiment (DoE) approach

Drug Development and Industrial Pharmacy, 2021
Objective The present study was aimed to design and optimize brimonidine tartrate (BRT) loaded cationic-charged liposome formulation with enhanced trans-corneal drug permeation, prolonged corneal residence, and sustained drug release for effective ocular
P. K. Soni, T. Saini
semanticscholar   +1 more source

Optimization and Characterization of Brimonidine Tartrate Nanoparticles-loaded In Situ Gel for the Treatment of Glaucoma

Current Eye Research, 2021
Purposes: The present study aimed to develop brimonidine tartrate loaded poly(lactic-co-glycolic acid) acid vitamin E-tocopheryl polyethylene glycol 1000 succinate (BRT-PLGA-TPGS) nanoparticles in thermosensitivein situ gel to improve mucoadhensive ...
P. Sharma, M. Chauhan
semanticscholar   +1 more source

Pupillometry Study of Brimonidine Tartrate 0.2% and Apraclonidine 0.5%

The Journal of Clinical Pharmacology, 2011
This study investigated possible effects of brimonidine tartrate 0.2% and apraclonidine 0.5% on pupil diameter. Ten subjects between 20 and 40 years of age participated. A Colvard pupillometer (Oasis Medical) was used to measure pupil diameter. Baseline and serial measurements were obtained at 3 luminance levels (>6.4,
Perla Najman, Kimberly Reed, Diana Shechtman, Patrick C. Hardigan, Eulogio Besada   +4 more
openaire   +3 more sources

Charles Bonnet Syndrome Precipitated by Brimonidine Tartrate

Journal of Medical Optometry
Charles Bonnet Syndrome (CBS) induced by brimonidine tartrate ophthalmic solution has rarely been reported. CBS is a condition characterized by visual hallucinations in patients with vision loss and clear cognition.
Shelly Kim
semanticscholar   +1 more source

Effect of Brimonidine Tartrate 0.15% on Scotopic Pupil: Controlled Trial

Journal of Ocular Pharmacology and Therapeutics, 2007
The aim of this study was to evaluate the duration of the effect of one single dose of brimonidine tartrate 0.15% on pupil diameter, under scotopic conditions, when applied topically in 1 eye of normal subjects.The eyes of 19 normal volunteers were randomized so that 1 eye had 1 drop of brimonidine tartrate 0.15% and the other received no medication ...
Gerente, Vanessa M., Biondi, Adriano C., Barbosa, Carolina P., Lottenberg, Claudio L., Paranhos, Augusto   +4 more
openaire   +4 more sources

Phase Transition Microemulsion of Brimonidine Tartrate for Glaucoma Therapy: Preparation, Characterization and Pharmacodynamic Study

Current Eye Research, 2021
Purpose: The aim of this study was to formulate brimonidine tartrate loaded phase transition microemulsions (PMEs), which undergo phase transition from water in oil (W/O) microemulsions to liquid crystalline (LC) and then oil in water (O/W ...
Nivedita Gautam, K. Kesavan
semanticscholar   +1 more source

Brimonidine tartrate for the treatment of facial flushing and erythema in rosacea

Expert Review of Clinical Pharmacology, 2014
Rosacea is a chronic inflammatory dermatologic condition that can often be disfiguring with significant negative impact on patients' quality of life. Sanrosa (brimonidine tartate) is a novel therapeutic agent targeting the facial flushing and erythema of rosacea through its α₂ adrenergic receptor agonist activity. The goal of this article is to discuss
Lana X. Tong, Angela Yen Moore
openaire   +3 more sources